Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
Ontology highlight
ABSTRACT: The muscle-specific ubiquitin ligase muscle ring finger-1 (MuRF1) is critical in regulating both pathological and physiological cardiac hypertrophy in vivo. Previous work from our group has identified MuRF1's ability to inhibit serum response factor and insulin-like growth factor-1 signaling pathways (via targeted inhibition of cJun as underlying mechanisms). More recently, we have identified that MuRF1 inhibits fatty acid metabolism by targeting peroxisome proliferator-activated receptor alpha (PPARα) for nuclear export via mono-ubiquitination. Since MuRF1-/- mice have an estimated fivefold increase in PPARα activity, we sought to determine how challenge with the PPARα agonist fenofibrate, a PPARα ligand, would affect the heart physiologically. In as little as 3 weeks, feeding with fenofi
SUBMITTER: Parry TL
PROVIDER: S-EPMC4754579 | biostudies-literature | 2016 Mar-Apr
REPOSITORIES: biostudies-literature
ACCESS DATA